HDR Gateway logo
HDR Gateway logo

Bookmarks

Covid-19

COVID-19

Description

As the national institute for health data science, the Health Data Research UK (HDR UK) community is actively championing the use of health data to address the global COVID-19 challenge. Institute members across our sites and hubs are contributing to this global challenge by forging partnerships with government, NHS, industry and academia. Teams are working on risk factors, genomics, clinical trials, care pathways and surveillance to help, for example, identifying which treatments and which clinical practices have the best outcomes for patients with COVID-19. These activities require access to and linkage of health data and we can build on our existing expertise and emerging capabilities to support this. You can learn more about our COVID-19 work here - https://www.hdruk.ac.uk/covid-19. This collection will feature resources and outputs addressing the COVID-19 challenge.

Datasets & BioSamples (38)

Avon Longitudinal Study of Parents and Children
Dataset population size: Unknown
Health and disease
COVID antigen testing - Pillar 1
Dataset population size: Unknown
Health and disease
COVID antigen testing - Pillar 2
Dataset population size: Unknown
Health and disease
Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II)
Dataset population size: Unknown
Health and disease
COVID-19 Detection from Chest X-Rays using Deep Learning
Dataset population size: Unknown
Health and disease

Analysis Scripts & Software (10)

COVID-19 Symptom Tracker App
HDRUK Super-User

Created - 06 September 2024

COVID-19 CovidSim Microsimulation Model
HDRUK Super-User

Created - 06 September 2024

BSTI COVID-19 Imaging Database
HDRUK Super-User

Created - 06 September 2024

COVID-19 Contact Tracing App - Android
HDRUK Super-User

Created - 06 September 2024

COVID-19 Contact Tracing App - iOS
HDRUK Super-User

Created - 06 September 2024

Public Health England COVID-19 Tracker
HDRUK Super-User

Created - 06 September 2024

Publications (478)

Longitudinal access and exposure to green-blue spaces and individual-level mental health and well-being: protocol for a longitudinal, population-wide record-linked natural experiment.
Mizen A, Song J, Fry R, Akbari A, Berridge D, Parker SC, Johnson R, Lovell R, Lyons RA, Nieuwenhuijsen M, Stratton G, Wheeler BW, White J, White M, Rodgers SE.
2019
Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020.
Russell TW, Hellewell J, Jarvis CI, van Zandvoort K, Abbott S, Ratnayake R, CMMID COVID-19 working group, Flasche S, Eggo RM, Edmunds WJ, Kucharski AJ.
2020
Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality.
Mohamed MO, Banerjee A, Clarke S, de Belder M, Patwala A, Goodwin AT, Kwok CS, Rashid M, Gale CP, Curzen N, Mamas MA.
2021
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts.
Wong AY, MacKenna B, Morton CE, Schultze A, Walker AJ, Bhaskaran K, Brown JP, Rentsch CT, Williamson E, Drysdale H, Croker R, Bacon S, Hulme W, Bates C, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, Tomlinson L, Mathur R, Wing K, Forbes H, Eggo RM, Parry J, Hester F, Harper S, Evans SJ, Smeeth L, Douglas IJ, Goldacre B, OpenSAFELY Collaborative.
2021
COVID-19 length of hospital stay: a systematic review and data synthesis.
Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, B Pearson CA, Group CW, Jombart T, Procter SR, Knight GM.
2020